iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.845
+0.005 (0.27%)
May 26, 2026, 1:06 PM EDT - Market open

iBio, Inc. Revenue

iBio, Inc. had revenue of $300.00K in the twelve months ending March 31, 2026, down -20.00% year-over-year. In the fiscal year ending June 30, 2025, iBio, Inc. had annual revenue of $400.00K with 77.78% growth.

Revenue (ttm)
$300.00K
Revenue Growth
-20.00%
P/S Ratio
222.89
Revenue / Employee
$15,000
Employees
20
Market Cap
66.68M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025400.00K175.00K77.78%
Jun 30, 2024225.00K--
Jun 30, 2023---
Jun 30, 20221.88M-487.00K-20.54%
Jun 30, 20212.37M733.00K44.75%
Jun 30, 20201.64M-380.00K-18.83%
Jun 30, 20192.02M1.57M354.50%
Jun 30, 2018444.00K50.00K12.69%
Jun 30, 2017394.00K-554.00K-58.44%
Jun 30, 2016948.00K-903.00K-48.78%
Jun 30, 20151.85M1.65M802.93%
Jun 30, 2014205.00K-802.00K-79.64%
Jun 30, 20131.01M-270.00K-21.14%
Jun 30, 20121.28M756.92K145.54%
Jun 30, 2011520.08K--
Jun 30, 2010---
Jun 30, 20091.18M189.54K19.20%
Jun 30, 2008987.06K90.79K10.13%
Jun 30, 2007896.27K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cue Biopharma32.73M
TScan Therapeutics9.14M
Immutep5.28M
BeyondSpring1.88M
ImageneBio800.00K
MediciNova596.64K
Entera Bio42.00K
Revenue Rankings